Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Miniature gastrointestinal endoscopy: Now and the future.

McGoran JJ, McAlindon ME, Iyer PG, Seibel EJ, Haidry R, Lovat LB, Sami SS.

World J Gastroenterol. 2019 Aug 14;25(30):4051-4060. doi: 10.3748/wjg.v25.i30.4051. Review.

2.

Outcomes from an international multicenter registry of patients with acute gastrointestinal bleeding undergoing endoscopic treatment with Hemospray.

Alzoubaidi D, Hussein M, Rusu R, Napier D, Dixon S, Rey JW, Steinheber C, Jameie-Oskooei S, Dahan M, Hayee B, Gulati S, Despott E, Murino A, Subramaniam S, Moreea S, Boger P, Hu M, Duarte P, Dunn J, Mainie I, McGoran J, Graham D, Anderson J, Bhandari P, Goetz M, Kiesslich R, Coron E, Lovat L, Haidry R.

Dig Endosc. 2019 Jul 31. doi: 10.1111/den.13502. [Epub ahead of print]

PMID:
31365756
3.

Intracorporeal lymph node mapping in colon cancer surgery.

Soares AS, Lovat LB, Chand M.

Eur J Surg Oncol. 2019 Dec;45(12):2316-2318. doi: 10.1016/j.ejso.2019.07.013. Epub 2019 Jul 16.

PMID:
31353062
4.

Reply to Dong et al.

Walter D, van den Berg MW, Hirdes MM, Vleggaar FP, Repici A, Deprez PH, Viedma BL, Lovat LB, Weusten BL, Bisschops R, Haidry R, Ferrara E, Sanborn KJ, O'Leary EE, van Hooft JE, Siersema PD.

Endoscopy. 2019 Jul;51(7):700. doi: 10.1055/a-0919-4867. Epub 2019 Jun 27. No abstract available.

PMID:
31247658
5.

Human-machine collaboration: bringing artificial intelligence into colonoscopy.

Ahmad OF, Stoyanov D, Lovat LB.

Frontline Gastroenterol. 2019 Apr;10(2):198-199. doi: 10.1136/flgastro-2018-101047. Epub 2018 Oct 15. No abstract available.

PMID:
31205664
6.

Artificial intelligence for the real-time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma: A proof-of-concept study.

Everson M, Herrera L, Li W, Luengo IM, Ahmad O, Banks M, Magee C, Alzoubaidi D, Hsu HM, Graham D, Vercauteren T, Lovat L, Ourselin S, Kashin S, Wang HP, Wang WL, Haidry RJ.

United European Gastroenterol J. 2019 Mar;7(2):297-306. doi: 10.1177/2050640618821800. Epub 2019 Jan 6.

7.

Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.

Magee C, Lipman G, Alzoubaidi D, Everson M, Sweis R, Banks M, Graham D, Gordon C, Lovat L, Murray C, Haidry R.

United European Gastroenterol J. 2019 Mar;7(2):217-224. doi: 10.1177/2050640618814659. Epub 2018 Nov 15.

8.

Implicit domain adaptation with conditional generative adversarial networks for depth prediction in endoscopy.

Rau A, Edwards PJE, Ahmad OF, Riordan P, Janatka M, Lovat LB, Stoyanov D.

Int J Comput Assist Radiol Surg. 2019 Jul;14(7):1167-1176. doi: 10.1007/s11548-019-01962-w. Epub 2019 Apr 15.

9.

Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.

Everson M, Magee C, Alzoubaidi D, Brogden S, Graham D, Lovat LB, Novelli M, Haidry R.

Dig Dis Sci. 2019 Oct;64(10):2815-2822. doi: 10.1007/s10620-019-05607-5. Epub 2019 Apr 13.

PMID:
30982210
10.

Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapy.

Sanagapalli S, Roman S, Hastier A, Leong RW, Patel K, Raeburn A, Banks M, Haidry R, Lovat L, Graham D, Sami SS, Sweis R.

Neurogastroenterol Motil. 2019 Jun;31(6):e13586. doi: 10.1111/nmo.13586. Epub 2019 Apr 7.

PMID:
30957312
11.

Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial.

Walter D, van den Berg MW, Hirdes MM, Vleggaar FP, Repici A, Deprez PH, Viedma BL, Lovat LB, Weusten BL, Bisschops R, Haidry R, Ferrara E, Sanborn KJ, O'Leary EE, van Hooft JE, Siersema PD.

Endoscopy. 2018 Dec;50(12):C12. doi: 10.1055/a-0843-5973. Epub 2019 Feb 6.

PMID:
30727006
12.

Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia.

Alzoubaidi D, Graham D, Bassett P, Magee C, Everson M, Banks M, Novelli M, Jansen M, Lovat LB, Haidry R.

Surg Endosc. 2019 Nov;33(11):3665-3672. doi: 10.1007/s00464-018-06655-0. Epub 2019 Jan 22.

13.

Management of non-variceal upper gastrointestinal bleeding: where are we in 2018?

Alzoubaidi D, Lovat LB, Haidry R.

Frontline Gastroenterol. 2019 Jan;10(1):35-42. doi: 10.1136/flgastro-2017-100901. Epub 2018 Feb 9. Review.

PMID:
30651955
14.

Artificial intelligence and computer-aided diagnosis in colonoscopy: current evidence and future directions.

Ahmad OF, Soares AS, Mazomenos E, Brandao P, Vega R, Seward E, Stoyanov D, Chand M, Lovat LB.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):71-80. doi: 10.1016/S2468-1253(18)30282-6. Epub 2018 Dec 6. Review.

PMID:
30527583
15.

A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom.

Pollit V, Graham D, Leonard C, Filby A, McMaster J, Mealing SJ, Lovat LB, Haidry RJ.

Curr Med Res Opin. 2019 May;35(5):805-815. doi: 10.1080/03007995.2018.1552407. Epub 2019 Jan 3.

PMID:
30479169
16.

Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.

Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R.

World J Gastroenterol. 2018 Nov 7;24(41):4698-4707. doi: 10.3748/wjg.v24.i41.4698.

17.

Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia.

Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ.

Gastrointest Endosc. 2019 Feb;89(2):247-256.e4. doi: 10.1016/j.gie.2018.09.032. Epub 2018 Oct 3.

PMID:
30291849
18.

Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists.

Sehgal V, Rosenfeld A, Graham DG, Lipman G, Bisschops R, Ragunath K, Rodriguez-Justo M, Novelli M, Banks MR, Haidry RJ, Lovat LB.

Gastroenterol Res Pract. 2018 Aug 29;2018:1872437. doi: 10.1155/2018/1872437. eCollection 2018.

19.

Robotics, artificial intelligence and distributed ledgers in surgery: data is key!

Chand M, Ramachandran N, Stoyanov D, Lovat L.

Tech Coloproctol. 2018 Sep;22(9):645-648. doi: 10.1007/s10151-018-1847-5. Epub 2018 Sep 21. No abstract available.

PMID:
30242534
20.

A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

Schiff ER, Frampton M, Semplici F, Bloom SL, McCartney SA, Vega R, Lovat LB, Wood E, Hart AL, Crespi D, Furman MA, Mann S, Murray CD, Segal AW, Levine AP.

Dig Dis Sci. 2018 Nov;63(11):3049-3057. doi: 10.1007/s10620-018-5219-9. Epub 2018 Sep 3.

21.

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Schiff ER, Frampton M, Ben-Yosef N, Avila BE, Semplici F, Pontikos N, Bloom SL, McCartney SA, Vega R, Lovat LB, Wood E, Hart A, Israeli E, Crespi D, Furman MA, Mann S, Murray CD, Segal AW, Levine AP.

Hum Genet. 2018 Sep;137(9):723-734. doi: 10.1007/s00439-018-1927-7. Epub 2018 Aug 22.

22.

Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).

Peerally MF, Bhandari P, Ragunath K, Barr H, Stokes C, Haidry R, Lovat L, Smart H, Harrison R, Smith K, Morris T, de Caestecker JS.

Gastrointest Endosc. 2019 Apr;89(4):680-689. doi: 10.1016/j.gie.2018.07.031. Epub 2018 Aug 1.

PMID:
30076843
23.

Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial.

Walter D, van den Berg MW, Hirdes MM, Vleggaar FP, Repici A, Deprez PH, Viedma BL, Lovat LB, Weusten BL, Bisschops R, Haidry R, Ferrara E, Sanborn KJ, O'Leary EE, van Hooft JE, Siersema PD.

Endoscopy. 2018 Dec;50(12):1146-1155. doi: 10.1055/a-0602-4169. Epub 2018 Jun 8. Erratum in: Endoscopy. 2018 Dec;50(12):C12.

PMID:
29883979
24.

Low night temperature at veraison enhances the accumulation of anthocyanins in Corvina grapes (Vitis Vinifera L.).

Gaiotti F, Pastore C, Filippetti I, Lovat L, Belfiore N, Tomasi D.

Sci Rep. 2018 Jun 7;8(1):8719. doi: 10.1038/s41598-018-26921-4.

25.

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression.

Pye H, Butt MA, Funnell L, Reinert HW, Puccio I, Rehman Khan SU, Saouros S, Marklew JS, Stamati I, Qurashi M, Haidry R, Sehgal V, Oukrif D, Gandy M, Whitaker HC, Rodriguez-Justo M, Novelli M, Hamoudi R, Yahioglu G, Deonarain MP, Lovat LB.

Oncotarget. 2018 May 1;9(33):22945-22959. doi: 10.18632/oncotarget.25159. eCollection 2018 May 1.

26.

A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix.

Zheng SC, Webster AP, Dong D, Feber A, Graham DG, Sullivan R, Jevons S, Lovat LB, Beck S, Widschwendter M, Teschendorff AE.

Epigenomics. 2018 Jul;10(7):925-940. doi: 10.2217/epi-2018-0037. Epub 2018 Apr 25.

27.

Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.

Cotton CC, Haidry R, Thrift AP, Lovat L, Shaheen NJ.

Gastroenterology. 2018 Aug;155(2):316-326.e6. doi: 10.1053/j.gastro.2018.04.011. Epub 2018 Apr 13.

28.

Impaired motility in Barrett's esophagus: A study using high-resolution manometry with physiologic challenge.

Sanagapalli S, Emmanuel A, Leong R, Kerr S, Lovat L, Haidry R, Banks M, Graham D, Raeburn A, Zarate-Lopez N, Sweis R.

Neurogastroenterol Motil. 2018 Mar 15. doi: 10.1111/nmo.13330. [Epub ahead of print]

PMID:
29542847
29.

How to Perform a High-Quality Examination in Patients With Barrett's Esophagus.

Everson MA, Ragunath K, Bhandari P, Lovat L, Haidry R.

Gastroenterology. 2018 Apr;154(5):1222-1226. doi: 10.1053/j.gastro.2018.03.001. Epub 2018 Mar 3. No abstract available.

PMID:
29510131
30.

Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.

Puccio I, Khan S, Butt A, Graham D, Sehgal V, Patel D, Novelli M, Lovat LB, Rodriguez-Justo M, Hamoudi RA.

Int J Exp Pathol. 2018 Feb;99(1):10-14. doi: 10.1111/iep.12260. Epub 2018 Feb 23.

31.

Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.

Kohoutova D, Haidry R, Banks M, Butt MA, Dunn J, Thorpe S, Lovat L.

Scand J Gastroenterol. 2018 May;53(5):527-532. doi: 10.1080/00365521.2017.1403646. Epub 2017 Nov 21.

PMID:
29161901
32.

Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.

Britton J, Gadeke L, Lovat L, Hamdy S, Hawkey C, McLaughlin J, Ang Y.

Lancet Gastroenterol Hepatol. 2017 Nov;2(11):824-831. doi: 10.1016/S2468-1253(17)30250-9. Epub 2017 Sep 1.

PMID:
28867477
33.

Systematic assessment with I-SCAN magnification endoscopy and acetic acid improves dysplasia detection in patients with Barrett's esophagus.

Lipman G, Bisschops R, Sehgal V, Ortiz-Fernández-Sordo J, Sweis R, Esteban JM, Hamoudi R, Banks MR, Ragunath K, Lovat LB, Haidry RJ.

Endoscopy. 2017 Dec;49(12):1219-1228. doi: 10.1055/s-0043-113441. Epub 2017 Jul 21.

PMID:
28732392
34.

Cost-effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett's esophagus.

Filby A, Taylor M, Lipman G, Lovat L, Haidry R.

J Comp Eff Res. 2017 Jul;6(5):425-436. doi: 10.2217/cer-2016-0089. Epub 2017 May 25.

35.

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.

Ross-Innes CS, Chettouh H, Achilleos A, Galeano-Dalmau N, Debiram-Beecham I, MacRae S, Fessas P, Walker E, Varghese S, Evan T, Lao-Sirieix PS, O'Donovan M, Malhotra S, Novelli M, Disep B, Kaye PV, Lovat LB, Haidry R, Griffin M, Ragunath K, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Ostler R, Aigret B, Sasieni PD, Fitzgerald RC; BEST2 study group.

Lancet Gastroenterol Hepatol. 2017 Jan;2(1):23-31. doi: 10.1016/S2468-1253(16)30118-2. Epub 2016 Nov 11. Erratum in: Lancet Gastroenterol Hepatol. 2017 Jul;2(7):e4.

PMID:
28404010
36.

Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate.

Adil Butt M, Pye H, Haidry RJ, Oukrif D, Khan SU, Puccio I, Gandy M, Reinert HW, Bloom E, Rashid M, Yahioglu G, Deonarain MP, Hamoudi R, Rodriguez-Justo M, Novelli MR, Lovat LB.

Oncotarget. 2017 Apr 11;8(15):25080-25096. doi: 10.18632/oncotarget.15340.

37.

The influence of procedural volume and proficiency gain on mortality from upper GI endoscopic mucosal resection.

Markar SR, Mackenzie H, Ni M, Huddy JR, Askari A, Faiz O, Griffin SM, Lovat L, Hanna GB.

Gut. 2018 Jan;67(1):79-85. doi: 10.1136/gutjnl-2015-311237. Epub 2016 Oct 18.

38.

Monitoring the premalignant potential of Barrett's oesophagus'.

Graham D, Lipman G, Sehgal V, Lovat LB.

Frontline Gastroenterol. 2016 Oct;7(4):316-322. Epub 2016 May 5. Review.

39.

A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy.

Pye H, Butt MA, Reinert HW, Maruani A, Nunes JP, Marklew JS, Qurashi M, Funnell L, May A, Stamati I, Hamoudi R, Baker JR, Smith ME, Caddick S, Deonarain MP, Yahioglu G, Chudasama V, Lovat LB.

Photochem Photobiol Sci. 2016 Oct 5;15(10):1227-1238. Epub 2016 Aug 9.

PMID:
27501936
40.

Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.

Levine AP, Pontikos N, Schiff ER, Jostins L, Speed D; NIDDK Inflammatory Bowel Disease Genetics Consortium, Lovat LB, Barrett JC, Grasberger H, Plagnol V, Segal AW.

Gastroenterology. 2016 Oct;151(4):698-709. doi: 10.1053/j.gastro.2016.06.040. Epub 2016 Jul 1.

41.

Comparing Kaolin and Pinolene to Improve Sustainable Grapevine Production during Drought.

Brillante L, Belfiore N, Gaiotti F, Lovat L, Sansone L, Poni S, Tomasi D.

PLoS One. 2016 Jun 13;11(6):e0156631. doi: 10.1371/journal.pone.0156631. eCollection 2016.

42.

Another modality to treat esophageal cancer?

Lovat L.

Gastrointest Endosc. 2016 Jun;83(6):1140-1. doi: 10.1016/j.gie.2016.02.003. No abstract available.

PMID:
27206582
43.

The new treatment paradigm for Barrett's dysplasia.

Lovat L.

Frontline Gastroenterol. 2016 Jan;7(1):30-31. doi: 10.1136/flgastro-2015-100584. Epub 2015 Mar 13. No abstract available.

44.

Reply to Kristo et al.

Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, Dunn JM, Gupta A, Sweis R, Miah H, Morris D, Smart HL, Bhandari P, Willert R, Fullarton G, Morris J, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O'Toole D, Cheong E, Direkze NC, Ang Y, Veitch A, Dhar A, Nyalender D, Ragunath K, Leahy A, Fullard M, Rodriguez-Justo M, Novelli M, Lovat LB.

Endoscopy. 2016 Jan;48(1):93. doi: 10.1055/s-0035-1569618. Epub 2015 Dec 28. No abstract available.

PMID:
26710283
45.

Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.

Di Caro S, Cheung WH, Fini L, Keane MG, Theis B, Haidry R, Di Renzo L, De Lorenzo A, Lovat L, Batterham RL, Banks M.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):251-60. doi: 10.1097/MEG.0000000000000536.

46.

Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile.

De Sordi L, Butt MA, Pye H, Kohoutova D, Mosse CA, Yahioglu G, Stamati I, Deonarain M, Battah S, Ready D, Allan E, Mullany P, Lovat LB.

PLoS One. 2015 Aug 27;10(8):e0135039. doi: 10.1371/journal.pone.0135039. eCollection 2015.

47.

Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.

Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, Dunn JM, Gupta A, Sweis R, Miah H, Morris D, Smart HL, Bhandari P, Willert R, Fullarton G, Morris J, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O'Toole D, Cheong E, Direkze NC, Ang Y, Veitch A, Dhar A, Nyalender D, Ragunath K, Leahy A, Fullard M, Rodriguez-Justo M, Novelli M, Lovat LB.

Endoscopy. 2015 Nov;47(11):980-7. doi: 10.1055/s-0034-1392414. Epub 2015 Jun 30.

PMID:
26126159
48.

Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.

Haidry R, Lovat L.

Curr Opin Gastroenterol. 2015 Jul;31(4):316-20. doi: 10.1097/MOG.0000000000000190. Review.

PMID:
26039723
49.

Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia.

Kohoutova D, Haidry R, Banks M, Bown S, Sehgal V, Butt MA, Graham D, Thorpe S, Novelli M, Rodriguez-Justo M, Lovat L.

Scand J Gastroenterol. 2015;50(11):1315-21. doi: 10.3109/00365521.2015.1043578. Epub 2015 May 8.

PMID:
25956748
50.

Radiofrequency ablation for Barrett's dysplasia: past, present and the future?

Haidry R, Lovat L, Sharma P.

Curr Gastroenterol Rep. 2015 Mar;17(3):13. doi: 10.1007/s11894-015-0433-5. Review.

PMID:
25740248

Supplemental Content

Support Center